What causes light‑headedness and dizziness in a patient taking amlodipine 10 mg and losartan 25 mg?

Lightheadedness and Dizziness on Amlodipine and Losartan: Evaluation and Management

Your patient's lightheadedness and dizziness is most likely caused by excessive blood pressure lowering (hypotension), a well-documented adverse effect of both amlodipine and losartan, particularly when used in combination. Check orthostatic vital signs immediately and measure seated blood pressure to determine if it has dropped below target.

Primary Mechanism: Drug-Induced Hypotension

Both medications independently cause hypotension as a known adverse effect. Dizziness occurs in 3% of patients on amlodipine versus 2% on placebo 1, while dizziness and lightheadedness are recognized side effects of losartan 2. The FDA label for losartan explicitly warns that "low blood pressure (hypotension) may cause you to feel faint or dizzy" and instructs patients to "lie down if you feel faint or dizzy" and "call your doctor right away" 2.

The combination of these two agents creates additive blood pressure lowering effects. While pharmacokinetic studies show no significant drug-drug interaction between amlodipine and losartan 3, their combined pharmacodynamic effect on blood pressure can be substantial.

Immediate Assessment Steps

Measure blood pressure in three positions:

• Supine after 5 minutes rest
• Seated after 1-2 minutes
• Standing after 1-3 minutes

Orthostatic hypotension is defined as:

• Drop in systolic BP ≥20 mmHg, OR
• Drop in diastolic BP ≥10 mmHg within 3 minutes of standing

Check for these specific findings:

• Current BP compared to baseline/target (goal <130/80 mmHg per current guidelines 4)
• Timing of symptoms relative to medication dosing
• Volume status (dehydration, vomiting, diarrhea) 2
• Concurrent medications that lower BP or cause volume depletion
• Serum creatinine and potassium levels

Management Algorithm

If BP is excessively low (<110/70 mmHg or symptomatic orthostasis):

1. Reduce or discontinue one agent - Consider stopping amlodipine first, as it has a longer half-life (35-50 hours) 5 and causes more dose-dependent dizziness than losartan. Losartan 25 mg is already a low dose.

2. If BP remains above target on monotherapy, restart the second agent at a lower dose after symptoms resolve.

3. Ensure adequate hydration - Volume depletion exacerbates orthostatic symptoms 2.

If BP is at or above target (≥130/80 mmHg):

The current regimen may be appropriate, but symptom timing matters. Amlodipine's long half-life means steady-state effects persist throughout the day, while losartan peaks 1-2 hours after dosing. Consider:

• Switching losartan timing (if taken in morning, move to bedtime)
• Reducing amlodipine to 5 mg if currently on 10 mg
• Monitoring for resolution over 1-2 weeks as tolerance develops

Alternative Considerations

Rule out other causes of dizziness:

• Cardiac arrhythmias (amlodipine can rarely cause bradycardia or atrial fibrillation 1)
• Anemia (reported with losartan 2)
• Hyperkalemia (losartan increases potassium 2)
• Vestibular disorders
• Hypoglycemia if diabetic

Medication-Specific Adverse Effects

Amlodipine causes:

• Peripheral edema (10.8% at 10 mg dose) 1
• Dizziness (3.4% at 5-10 mg) 1
• Flushing, palpitations 1

Losartan causes:

• Dizziness (reported in controlled trials) 2
• Hypotension (particularly in volume-depleted patients) 2
• Upper respiratory infection, back pain 2

Key Clinical Pitfalls

Do not dismiss symptoms as "adjustment period" - While some tolerance develops, persistent symptomatic hypotension requires intervention. The FDA label explicitly instructs patients to contact their physician for these symptoms 2.

Avoid adding a third antihypertensive without first addressing the current symptoms. The 2020 ISH guidelines recommend simplifying regimens and using once-daily dosing 4, not adding complexity when adverse effects occur.

Monitor renal function and potassium - Both medications can affect kidney function, and losartan increases potassium levels 2. Worsening renal function can contribute to medication accumulation and hypotension.

Consider timing of symptom onset - If symptoms began shortly after starting or increasing doses, this strongly suggests drug-related hypotension rather than other causes.

The evidence consistently shows these symptoms represent a predictable pharmacological effect requiring dose adjustment or medication change, not a rare idiosyncratic reaction 2, 1, 6.